San Jose State University

SJSU ScholarWorks
Doctoral Projects

Master's Theses and Graduate Research

5-2019

Human Papillomavirus Vaccine Program
Magdalena Ruiz
California State University, Northern California Consortium Doctor of Nursing Practice

Follow this and additional works at: https://scholarworks.sjsu.edu/etd_doctoral
Part of the Pediatric Nursing Commons

Recommended Citation
Ruiz, Magdalena, "Human Papillomavirus Vaccine Program" (2019). Doctoral Projects. 107.
DOI: https://doi.org/10.31979/etd.d9e2-pyvy
https://scholarworks.sjsu.edu/etd_doctoral/107

This Doctoral Project is brought to you for free and open access by the Master's Theses and Graduate Research at
SJSU ScholarWorks. It has been accepted for inclusion in Doctoral Projects by an authorized administrator of SJSU
ScholarWorks. For more information, please contact scholarworks@sjsu.edu.

ABSTRACT
HUMAN PAPILLOMAVIRUS VACCINE PROGRAM

Pediatric primary care focuses on maintaining patients’ health, preventing
diseases, and assessing children’s developmental milestones. Vaccine
administration and disease prevention are key components of a well-child exam
for pediatric patients; however, vaccine refusal is an important complication of
pediatric patient care. Of particular interest to this researcher is the HPV vaccine
which was approved by the Federal Drug Administration and is currently
recommended by the Centers for Disease Control and Prevention (2016) for both
males and females, beginning at 11 or 12 years of age through age 26 years. The
HPV vaccine protects against diseases and cancers caused by the HPV virus; thus,
it is important that primary caregivers of pediatric patients be informed about the
benefits of this vaccine to ensure that more caregivers give their consent to
administer the vaccine. This Doctor of Nursing Practice (DNP) project was
designed to evaluate parental refusal for the human papillomavirus (HPV) vaccine
via in-person interviews, vaccine teaching sessions, and a subsequent evaluation of
the effect of these sessions on parental consent to the HPV vaccine. This project
took place in a rural pediatric health clinic, and a total of 12 parents completed the
one-month follow-up phone assessments. The results of this study noted a positive
impact of the vaccine teaching sessions on the parental decision to consent to the
HPV vaccine in the clinic, revealing that seven parents (58%) changed their
decision from refusing the HPV vaccine to consenting to its administration.
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CHAPTER 1: INTRODUCTION
Introduction
As a nurse practitioner working in a rural healthcare setting, the author of
this study understands that preventative healthcare is a priority in medical practice.
The focus of preventative healthcare is to prevent disease, and one way to
accomplish this is to administer vaccines recommended by the Centers for Disease
Control and Prevention (CDC). As advised and scheduled by the CDC and
approved by the American Academy of Pediatrics (AAP) (2013), vaccines have
been shown to protect against life threatening illnesses (CDC, 2016). This study
focused on the human papillomavirus vaccine (HPV) which prevents infection
from strains that are associated with many cancers, including throat, cervical, oral,
and penile (CDC, 2016). The HPV vaccine is recommended at age nine years for
both female and male pediatric patients. The goal of this project for the Doctor of
Nursing Practice, (DNP) was to create an HPV program which determined the
reasons for parental refusal and implemented a vaccine education program for
parental providers which could increase vaccine compliance and vaccine
completion series rates.
Background
Immunization is the process whereby a person is made immune or resistant
to an infectious disease, typically by the administration of a vaccine (World Health
Organization [WHO], 2015). The Food and Drug Administration has approved
three vaccines that prevent infection due to HPV strains: Gardasil, Gardasil 9, and
Cervarix (National Cancer Institute [NCI], 2018). HPV is a very common virus
with nearly 80 million people—about one in four—currently infected in the
United States (CDC, 2016). About 14 million people, including teens, become
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infected with HPV each year (CDC, 2016). Risks of the HPV virus vary, but the
most serious conditions include oral cancer, genital cancer, genital warts, and
cervical cancer (CDC, 2016). According to research conducted by the CDC,
adolescents in rural areas obtain the HPV vaccine less often than those who live in
urban areas (CDC, 2018). The vaccine is routinely given at 11 or 12 years of age,
but it may be given as early as age nine and as late as age 26 (CDC, 2016).
Vaccine completion is as follows: adolescents 9 through 14 years of age receive
the HPV vaccine as a two-dose series with the doses separated by 6 - 12 months;
individuals who begin HPV vaccination at 15 and older should get the vaccine as a
three-dose series with the second dose given 1 - 2 months after the first dose and
the third dose given 6 months after the first dose (CDC, 2016). Parental refusal to
allow the administration of the HPV vaccine has been identified as a common
obstacle in vaccine compliance and health promotion in adolescent patients who
live in rural areas. According to the National Cancer Institute at the National
Institute of Health, the combination of HPV vaccination and cervical screening
can provide the greatest protection against cervical cancer (NCI, 2018). The
primary goal of this vaccine program research project was to encourage
caregivers/parents to consent to the administration of the HPV vaccine to their
children by providing the former with information that focused on the importance
of HPV disease prevention and vaccine education. The implementation of vaccine
education programs such as this in other healthcare settings may lead to positive
changes that will increase HPV vaccine compliance and decrease parental vaccine
refusal.
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Problem Statement
Vaccine compliance and parental refusal have become issues that advanced
practice nurses need to address. Despite the importance of vaccines in preventing
communicable diseases, there has been a large increase in vaccine refusal in the
21st century (WHO, 2015). Globally, one in five children still does not receive
routine life-saving immunizations, and an estimated 1.5 million children still die
each year of diseases that could have been prevented by vaccines that are already
in existence (WHO, 2015). In primary care settings, such as rural healthcare
clinics where pediatric patient care is provided, there has been an increase in
parental refusal to vaccines, including the HPV vaccine. According to a survey
conducted by the Academy of Pediatrics in 2009, 11.5% of parents with children
17 years and younger reported refusing at least one vaccine (American Academy
of Pediatrics [AAP], 2013). Through the evaluation of parental vaccine
knowledge, promoting provider/parent communication, and implementing a
vaccine program, this study identified barriers to vaccine compliance.
Purpose of the Project
The purpose of this HPV vaccine program was to identify and address
barriers for vaccine refusal for adolescent patients in the rural healthcare clinic
setting. Additional goals of this program were to evaluate the impact of a vaccine
education program on vaccine compliance, increase vaccine rates in a rural health
care clinic, and determine whether or not provider/parental dialogue could
improve the likelihood of parents agreeing to the HPV vaccine series.
The emphasis of public healthcare is to address barriers affecting a specific
patient population. In caring for pediatric patients in the rural healthcare setting, it
is important to acknowledge parents’ behavior toward their children’s healthcare
interventions, including immunizations. In providing patient care, advanced
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practice nurses can use various nursing theories to help impact patient care and
health outcomes.
Theoretical Framework and Application to Practice
The health belief model (HBM) is the nursing theory that may be applied to
the vaccine non-compliance issue and vaccine parental refusal in the pediatric
primary care setting. The HBM is a theory that focuses on health behavior which
was originally developed in the 1950s to predict whether individuals would be
willing to engage in programs aimed at preventing and detecting disease (Gerend
& Shepard, 2012). The HBM was first developed by social psychologists working
in public health services within the U.S. The social psychologists who developed
the model looked at ways to explain why so few people were participating in
programs aimed at preventing and detecting disease (Butts & Rich, 2018). During
the 1950s, HBM was used to evaluate the polio vaccine and its risks for public
health. The factors identified soon became the basis for the HBM and have been
used throughout the public healthcare field to explain why people adopt behaviors
that lead to better health (Smith, et al., 2011). Researchers included six main
constructs pertaining to the model: perceived susceptibility, perceived severity,
perceived benefits, perceived barriers, cue to action, and self-efficacy (Butts &
Rich, 2018). Focusing on the identified six constructs regarding parents’ views on
disease prevention may guide vaccine programs to work toward increasing vaccine
compliance and preventing or decreasing parental vaccine refusal.
To conduct the HPV vaccine program, this researcher addressed the abovementioned HBM constructs in the following manner:
1. Perceived susceptibility of HPV infection: educate parents on HPV risk
and infection.
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2. Perceived severity of disease: explain HPV risks in causing cervical
cancer.
3. Perceived benefits: explain that decreasing the risk of HPV may
decrease the risk of diseases, including oral and cervical cancer.
4. Perceived barriers: explain that complying with scheduled vaccine doses
may prevent HPV infection.
5. Cue to action: provide advanced practice nurse recommendation and a
parent/provider education time.
6. Self-efficacy: obtain parental permission to administer vaccine to
adolescent patient.
This vaccine program used these six constructs of the HBM as a guide in
acknowledging parental feelings toward vaccines and to work toward increasing
the vaccine compliance rate. Focusing the HBM in this research study not only
helped this researcher identify strategies to change health behaviors regarding
vaccine compliance, but it may also continue to guide advance practice nurses to
implement changes that may benefit their pediatric patients.
Summary
A key element to advanced practice nurses is focusing on preventative
health measures while providing primary care to patients. When caring for
pediatric patients, it is important to acknowledge parental concerns and health
beliefs while creating parental/provider rapport which may improve patient
healthcare outcomes. The following HPV vaccine program may assist health care
providers, such as nurse practitioners, in determining factors associated with
parental vaccine refusal. Identifying these barriers to vaccine compliance may
then guide interventions needed for increasing vaccine compliance rates in

6
pediatric rural healthcare clinics. The following chapter reviews the literature
which examined the reasons for parental HPV vaccine refusal.

CHAPTER 2: LITERATURE REVIEW
During the research aspect of this HPV vaccine program, the literature was
reviewed regarding parental concerns about administering the HPV vaccine to
their children. The primary database used for this research was California State
University, Fresno’s online library search engine, including search websites such
as Science Direct. Most of the research suggested that education and
misconceptions are among the leading reasons for refusal of the HPV vaccine
(Kinder, 2016). This literature review examines various studies which identified
reasons for parental refusal of the HPV vaccine and also examines the gaps in
research which were identified in the vaccine program conducted by this
researcher.
Parental Refusal of the HPV Vaccine
Primary Caregiver Views on HPV
Vaccine.
Kinder (2016) examined and evaluated parental refusal of the Gardasil Vaccine
in a pediatric clinic. This study used a mixed-methods approach using parental
surveys that were conducted after visits in which parents had deferred the Gardasil
Vaccine. Kinder (2016) collected 23 surveys. A descriptive statistics approach
was used to analyze the data collected in survey answers. The results in answers
varied, but most parents (75%) deferred administration of the HPV vaccine
because they believed it was too new or required further research (Kinder, 2016).
One limitation to this study was the sample size; this study was a pilot study, but it
seemed to confirm and share findings with other studies concerning the vaccine
(Kinder, 2016). A strength to this study included the determination of
implications for nurse practitioners: recommendations of necessary changes to and
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new strategies in the approach nurse practitioners use in offering the Gardasil
vaccine (Kinder, 2016).
Medical Provider Views on Vaccine
Refusal.
Fleming, Sznajder, Nepps, and Boktor (2018) utilized a different approach
and researched the healthcare providers’ points of view toward Gardasil vaccine
education programs as well as their views on barriers to the administration of the
Gardasil vaccine. This study took place in Pennsylvania and surveyed providers
who practiced within the federally funded Vaccines for Children (VFC) program.
The design of this research was cross-sectional; data were gathered using emailed
surveys which contained 18 questions that were obtained from the validated PA
VFC program’s “Annual Program Satisfaction Survey” (Fleming, Sznajder,
Nepps, & Boktor, 2018, p. 449). The survey used three types of questions: closedended, Likert-scale, and open-ended. Descriptive studies were used to analyze the
data. After contacting 1478 providers via email surveys, a total of 772 surveys
were completed. In the study, the healthcare providers’ facilitators and barriers to
human papillomavirus (HPV) vaccination were evaluated (Fleming et al., 2018).
The survey results concluded that the most important factor identified by providers
was counseling parents and adolescents on the benefits of HPV vaccination,
(79.5%). The findings of this study indicated that the providers identified that
parental concerns about the HPV vaccine and sexual behavior are barriers to the
HPV vaccine (Fleming et al., 2018). This study also revealed that providers
preferred web-based training regarding vaccine education. The strengths of this
research included the identification of vaccine education programs for
pediatricians, an emphasis on pediatrician views on parental vaccine refusal. The
latter may guide pediatric practice vaccine programs for providers and parents.
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Furthermore, a final strength of this study was its large sample size. The
limitations of this study pertained to respondents and the lack of a pilot survey: not
all respondents were pediatricians, and a pilot survey was not conducted prior to
using the survey during research study; this could have potentially created an issue
during data collection (Fleming et al., 2018).
Pediatrician Point of View on
Vaccine Refusal.
Leib, Liberatos, & Edward (2011) conducted a quantitative study, in which
surveys were sent to 600 pediatricians. The pediatricians were chosen randomly
via a computer during November and December 2007, and surveys were returned
by February 2008 (p. 14). The sample consisted of a total of 133 pediatricians (a
31% response rate) who filled out a 28-item survey via mail. The study took place
in pediatric clinics in Connecticut. The pediatricians who participated in surveys
were all members the Hezekiah Beardsley Connecticut Chapter of the AAP and
received consent from the organization to participate (p. 14). The pediatricians
were asked questions focusing on providers’ experiences with family vaccine
refusal, identifying the vaccines being refused, and whether physicians dismissed
these families from their practice. The data analysis was conducted using a chisquare analysis. The results showed that nearly three-quarters of the pediatricians
reported “an increase in parental concerns and refusals compared with 10 years
ago” (Leib, Libratos, & Edward 2011, p.16). One strength of the study was its
focus on the pediatricians’ point of view rather than just parental thoughts on the
Gardasil vaccine. The low response rate of 31%, is a limitation to the study. It
would be helpful to obtain a larger response rate to help identify further patterns
leading to parental vaccine refusal. (Leib et al., 2011).
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Javaid et al. (2017) conducted a study on the barriers to the Gardasil
vaccine. The researchers sent surveys via email to medical facilities in the state of
Texas. There was a total of 1132 responses that were received, representing
healthcare providers, administration, and other managerial staff. A descriptive
statistics analysis was conducted using the survey software, Qualtrics. Javaid et
al. (2017) found that parental perceptions about HPV, parental knowledge, and
safety concerns were barriers affecting Gardasil vaccine rates (Javaid et al., 2017).
Providers stated that vaccine refusal was primarily related to misconceptions about
the HPV disease, the safety of the vaccine, and society’s views about why the
vaccine should be administered. The nursing implications of this study are that
such misconceptions should be addressed when providing patient care, and parents
should be educated about the vaccine’s purpose; this may help increase
vaccination rates and decrease vaccine refusal. A limitation of this study would be
the mode of survey distribution via email. Methods such as in-person interviews
and follow-up surveys may increase survey distribution and response rate. In this
study, the respondents varied in profession and medical background; focusing on
primary care providers such as physicians, nurse practitioners, and physician
assistants may provide a better evaluation of parental barriers to vaccine
administration. Parents often consider the medical advice given to them by their
primary care provider the best for their children’s health decisions. Parents may
rely on the primary care providers’ medical advice to make decisions about
medical care, including preventative care such as vaccines (Javaid et al., 2017).
Health Belief Model Impact on Vaccine Refusal.
Krawczyk et al. (2015) conducted a study to identify key differences
between parents who consented and parents who refused the Gardasil (HPV)
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vaccine for their daughters. This study took place in a free vaccination clinic in
Quebec, Canada, and included a large randomized sample size and return rate.
Parental surveys were sent and returned via mail. A total of “834 parents returned
the questionnaire, and the overall response rate was 33%. Of those, 774 (92.8%)
questionnaires had complete data for all relevant items and were included in the
present quantitative analyses” (Krawczyk et al., 2015, p. 324). Those surveyed
were parents of girls who were 9 to 10 years of age. Of these 774 participating
parents, 88.2% reported that their daughters received the HPV vaccine. The
theoretical framework used for this study was the HBM which was used to
investigate whether parental beliefs about the Gardasil vaccine guided their
decision to vaccinate their daughters (Krawczyk et al., 2015). The study focused
on how the HBM influenced parental perceptions in their decision to vaccinate
their daughters and how the knowledge of the Gardasil vaccine guided
interventions and vaccine programs. A limitation of this study was that it only
included parents attending a free vaccine clinic; thus, the results may not be
applicable to parents of children with insurance (Krawczyk et al., 2015).
Vaccine Education.
Lechuga, Swain, and Weinhard (2012) conducted a study to evaluate
parental decisions to consent to the Gardasil vaccine as a result of the use of the
Decision Aid (DA). The DA is a tool that guides parents through their decision to
vaccinate their children by explaining what the vaccine is/does and addressing
parental concerns regarding a specific vaccine. This study was a mixed method
study using a survey approach which took place within four Health Department
clinics in Milwaukee, Wisconsin. The sample group consisted of 150 mothers of
girls, aged 9 - 17 years, who had not received the vaccine and were receiving WIC
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assistance from one of four clinics in Milwaukee. The mothers completed
questionnaires which focused on intention to vaccinate, emotions toward the
Gardasil vaccine, the vaccination of boys, and the use of a DA. The
questionnaires also assessed ethnicity, age, years of education, insurance, and
employment status. The researchers “conducted a content analysis to investigate
emergent themes in answers to the open-ended item assessing vaccination related
concerns” (Lechuga, Swain, & Weinhard, 2012, p. 217). A chi-square analysis,
ANOVA, was used to analyze quantitative data. Results showed that, overall,
mothers benefitted from a DA to assist them in understanding the purpose of the
Gardasil vaccine. With regard to ethnic groups, African American mothers found
the decision aid useful in their decision-making process. Hispanic mothers
verbalized benefiting from hearing other parents’ experience with the Gardasil
vaccine. This study also found the need for physician guidance in parental vaccine
compliance. In this study, there was a low parental (mother) concern regarding
the vaccine’s initiation of early sexual behavior in their children, these results
were “3% of Hispanics, 6% of African American, and 7% of non-Hispanic White”
(Lechuga et al., 2012, p. 219). A strength of the study was that data were
collected from four health departments. In addition, the study was able to evaluate
various ethnic groups; this may help providers focus on specific parental views of
the vaccine. A limitation of this study is that the sample group only included
mothers of girls who did not receive a vaccine; no mothers of boys were surveyed.
This study could be changed to include mothers of all adolescents—both boys and
girls—to further look at parental consent or refusal to vaccinate (Lechuga et al.,
2012).
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Impact of Parent and Provider Communication.
Rahman, Laz, McGrath, and Berenson (2015) evaluated the association
between parental HPV awareness and Gardasil vaccine initiation/completion rates
in adolescent children 13 to 17 years of age (p. 371). The study examined whether
or not communication with a provider impacted parents’ decisions to administer
the Gardasil vaccine to their adolescent children. The researchers used crosssectional surveys already completed via the CDC which were national
immunization surveys of teens aged 13 - 17 years. Statistical data were analyzed
using STATA 12 svy command and logistic regression models to examine the
independent variable and dependent variable. The sample size was large: 11,236
adolescent girls and 12,328 adolescent boys. Overall, the study noted the
importance of including provider recommendation of vaccine programs in the
United States to increase Gardasil vaccine administration. A strength in this study
was its use of data from a reliable source, the CDC. A limitation in this study was
its lack of examples (such as program websites, parental teaching handouts, or
vaccine education tools) of how providers might improve communication with
their patients and their parents to increase Gardasil vaccine success rates (Rahman,
Laz, McGrath, & Berenson, 2015).
Brown, Gabra and Pellman (2017) examined reasons for parents’
acceptance or refusal of the HPV vaccine in a pediatric practice. The study was
conducted over a period of one year, using parental surveys and evaluating the
reasons for agreeing or refusing initial HPV vaccination following a practitioner
recommendation (Brown, Gabra, & Pellman, 2017, p. 42). Parents were surveyed
after their children’s doctor appointments at which HPV vaccine education was
provided by the provider. A total of 200 parents participated in surveys,
answering questions about demographics and reasons for accepting or refusing the
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vaccine. In evaluating the data collected, “a univariate descriptive statistic was
used to examine age, gender, familial/friend diagnosis, and reasons for or against
vaccination” (Brown, et al., 2017, p. 43). The study revealed that the physicians’
recommendation was the major factor (84.1%) in parents’ decisions to administer
the HPV vaccine to their children (Brown et al., 2017). The most common reason
identified for vaccine refusal was the need for further research (Brown et al., 2017,
p. 43). The survey’s small sample size was considered a limitation to the study.
Overall, the researchers found that physician recommendation for HPV vaccine
influenced parental decision in accepting the vaccine for their child.
Teaching Tool Evaluation.
Cipriano, Scoloveno, and Kelly (2018) also examined parental attitudes and
consent or refusal of the HPV vaccine by evaluating a parental intervention
focused on increasing parental knowledge of the HPV vaccine. The study took
place in a pediatric clinic in the state of New Jersey, using a pre- and postintervention design. The researchers used a computer-based training module in
which parents were given the HPV vaccine education and then were given post
surveys. A limitation noted by the researchers was the possibility of parental
misunderstanding of the vaccine information that was given to Spanish-speaking
parents on the digital tablet they were provided. The researchers concluded that
the main reasons for parental refusal for the HPV vaccine was a lack of
understanding regarding the HPV vaccine and children were not sexually active at
the time of the administration of the vaccine. Overall, the study focused on
increasing parental comprehension of the HPV vaccine, and the results indicated
that there was an increase in knowledge.
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Summary
An examination of past research studies which focused on parental refusal
of the HPV vaccine highlighted gaps regarding provider/parental communication,
vaccine education, and parental comfort with vaccine side effects. Therefore, it is
necessary for advance practice nurses to address parental feelings about the HPV
vaccine, for this may positively influence patient health outcomes. If such
intervention is implemented in the healthcare system, advance practice nurses will
have the opportunity, through consultations, to build trusting relationships with
parents. The following chapter outlines the HPV vaccine program in which
vaccine refusal, vaccine education, and parental/provider rapport are evaluated.

CHAPTER 3: METHODOLOGY
Project Design
In this study, a qualitative content analysis was conducted to evaluate the
reasons for parental refusal of the HPV vaccine. The purpose of this study was to
interview 10 - 12 parents who had refused the HPV vaccine for their adolescent
children and determine the reasons for this refusal. Through this study, the
researcher provided each parent with a teaching session followed by a follow-up
interview over the phone one month later to assess outcomes and determine if the
teaching session had changed parental decisions to refuse the vaccine.
Program Setting
The HPV vaccine program and interviews took place at Dr. Javier Amu
Professional Corporation, a rural pediatric healthcare clinic located in Reedley,
California. Interviews with parents were conducted by this researcher in a
conference room at this clinic. Additionally, phone call assessments were
conducted using the confidential phone in the clinic office.
Sample Population
The subject population included parents who had refused the HPV vaccine
for their adolescent children and who received primary care in the rural health
clinic.
Recruitment of Participants
The study subjects consisted of parents who obtained pediatric patient care
services for their adolescent children in this pediatric rural healthcare clinic. The
researcher obtained Institutional Review Board (IRB) approval from the California
State University, Fresno, and from Dr. Amu, the pediatrician/owner of the rural
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health clinic, prior to beginning the research study and parental interviews (see
Appendices F and G).
Sampling Procedures
Participants for the interviews and the phone call assessments were
collected through the clinic’s electronic medical record, PRAXIS. Adolescent
patients who were delinquent with any of the HPV vaccine doses were identified,
and parental information was obtained. The researcher contacted each
parent/participant and asked for voluntary participation in interview and phone call
assessment for this vaccine program. After parents agreed to participate in this
study, informed consents which explained the research study program were
obtained, and the researcher then initiated interviews (see Appendix H).
Ethical Considerations
Risk from ethical problems in this study was minimal, for informed consent
was obtained from parents (study subjects) prior to in-person interviews and
phone-call assessments. This study was approved by the IRB at California State
University, Fresno.
Measures
Using a qualitative research design by means of semi-structured face-toface interviews, the researcher identified and evaluated reasons for parental HPV
vaccine refusal. After implementing a parental teaching session, follow-up phone
call assessments took place one month later to evaluate parental decisions to
accept or refuse the HPV vaccine.
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Research Design
Data Collection Methods
The parental interview addressed the four survey questions which were
used as part of Kinder’s (2016) research in evaluating parental refusal of the HPV
vaccine (see Appendix A). Permission to use these questions for the purposes of
this study was obtained from assistant professor at La Salle University, Frances
DiAnna Kinder, PhD, RN (see Appendix B). For this project, this researcher
asked the following questions to assess vaccine refusal:
1. How many times has the vaccine been offered to you?
2. Where do you obtain most of your medical information? (Kinder, 2016,
p. 555).
3. What was your reason for refusal of HPV vaccine for your child?
4. What would influence your decision to consent for HPV vaccine easier?
(See Appendix A).
As part of the interview, the following demographics were requested: relationship
to child, educational level of parent, parental age, and patient age and sex (see
Appendix C).
The second component of the HPV vaccine program was an educational
teaching session with parents. The researcher included all of the recommended
vaccines in the teaching session such as HPV infection information, HPV vaccine,
and a vaccine schedule calendar. A 10-minute educational session was provided
to each parent which took place in the same session as the interview, using a
resource tool provided by the CDC, “6 Reasons to Get HPV Vaccine for Your
Child” (CDC, 2018). (See Appendix D). The resource tool was provided in the
parents’ native speaking language (Spanish or English). If parents had requested
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information in a different language, the researcher would have provided the
information as needed, however no other language resources were required.
The third component to this vaccine program consisted of a follow-up
phone call assessment conducted by the primary researcher one month after the
appointment at the health clinic. Each parent that was interviewed and
participated in the teaching session received a call. The questions asked were as
follows:
1. Can you remember why you refused HPV vaccine for your child?
2. What did you learn about the HPV vaccine after the teaching session?
3. Has your opinion changed about consenting to the vaccine for your
child? If so, why?
4. Will you consent for refuse HPV vaccine for your child?
The primary researcher followed a detailed script while conducting each
phone call assessment (see Appendix E).
After the interviews, teaching sessions, and follow-up phone calls took
place, parental responses were evaluated to determine whether there were any
specific or common barriers/themes to parental refusal of the HPV vaccine. A
content analysis was conducted as an evaluation of the effectiveness of the
teaching session for parental decision to consent for the HPV vaccine. As
previously described, the data analysis method was a qualitative study using semistructured interviews with parents who refused the HPV vaccine for their
adolescent children aged 11 – 17 years.
Data Analysis
The content analysis included the data/answers gathered from interviews
and follow-up phone call assessments which were completed during this vaccine
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program. As defined in Melnyk and Fineout-Overholt (2015), content analysis
involves extracting themes, patterns, processes, essences, and meanings from
textural data. Based on these findings, future studies may be implemented,
addressing parental concerns and reasons for the refusal of the HPV vaccine.
Summary
Parent interviews and phone-call assessment answers were evaluated and
identified in relation to barriers to HPV vaccine acceptance and reasons for HPV
vaccine refusal. This vaccine program also focused on parental/provider
education and analyzed its influence on parental acceptance or refusal of the HPV
vaccine. Results of this study will provide further vaccine program interventions,
education tools, and parental support for increasing parental vaccine compliance.
In the following chapter, there is a content analysis discussion on the results of the
HPV vaccine study.

CHAPTER 4: RESULTS
This chapter summarizes this vaccine program’s in-person interviews,
follow-up phone-call assessments, and patient and parent demographics. The
qualitative research study design includes the content analysis conducted with data
collected during the vaccine program.
Sample Characteristics
This study included 13 parents who participated in the vaccine program,
including in-person interviews, teaching sessions, and phone-call assessments.
Table 1 shows the demographic information of the 13 parents who participated in
the study. The interviewed participants included a total of two fathers and 11
mothers. Parental age groups varied from 31 to 52 years of age. Parents’
education levels varied from a completion of the sixth grade to a college
bachelor’s degree. Ethnicity also varied: there was one White father, one Native
American mother, one Hispanic American mother, and 10 Hispanic parents who
participated in the study. The sex and age of the participants’ children were also
identified as part of the demographic information for the study. Seven parents had
female children (54%), while six parents had male children (46%). The children’s
ages varied from 11 to 14 years.
In-person Interviews Data Analysis
Qualitative
A total of 13 in-person parental interviews were conducted by the
researcher and took place in the conference room of the clinic. The following
section reviews the data collected during the interviews which used four openended questions. The first interview question asked about the amount of times the
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HPV vaccine had been offered to the parents. One parent stated, “The vaccine has
never been offered to me” (8%). Six parents (46%) verbalized that the vaccine
had been offered once. There were two parents (15%) who said the vaccine was
offered twice. Three parents (23%) claimed that the vaccine was offered three
times. One parent (8%) stated the vaccine was offered multiple times.
Table 1. Demographic Characteristics of the Participants (N=13)
Characteristic
Percentage
Relationship to patient
Mother
84.6
Father
15.4
Parental age
31-40
46.2
41-48
23.1
>49
30.7
Parental education level
Sixth grade
15.4
Junior High School
7.7
High School
38.5
Some college – Bachelor’s
38.5
Parent Ethnicity
White
7.7
Hispanic
84.6
Native American
7.7
Patient sex
Male
46.2
Female
53.8
Patient age
11-12
61.5
13-14
38.5
The second question of the interview asked parents where they obtained
their medical information, and answers included the internet, clinic, medical
providers, and research articles. A couple of parents stated that they obtained
medical information from multiple sources. A total of nine parents (69%)
obtained their information from the medical clinic or doctor. There were eight
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parents who stated they received their medical information from websites (61%).
Three parents (23%) obtained their information from research-based articles/data.
Reasons for Parental Vaccine
Refusal
Lack of information or vaccine education. Interview data for questions
three and four are discussed using themes in qualitative content analysis. The
third assessment question addressed the reasons for parental refusal of the HPV
vaccine. The largest theme/reason verbalized by parents for their refusal of the
vaccine was the lack of education or information provided regarding the purpose
for the HPV vaccine. Parents verbalized not “knowing and understanding” the
HPV virus and how the vaccine prevented cervical cancer and genital warts. In
reviewing these data, a common theme for parental refusal of the HPV vaccine, as
verbalized by many parents, was their fear of the vaccine’s side effects.
Vaccine side effects. During the interviews, a frequent concern and reason
for refusal that was voiced by many parents was the side effects of the vaccine.
Whether the parents misunderstood the side effects or read about the side effects
online, it was clear that these views impacted parents’ decisions to refuse the
vaccine for their children. One parent stated, “I read a story online in which a
young lady received the HPV vaccine and went into a vegetative state.” Another
mother stated that she had refused the HPV vaccine because she was “worried
[her] daughter could have a reaction to the vaccine.” To address parental concerns
about side effects, there is a Vaccine Information Sheet (VIS) that is provided
during patients’ physical exam at recommended age that identifies the possible
side effects of the HPV vaccine.
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Young age of patient at the time of HPV vaccination. During the
parental interviews, three out of the 13 parents expressed their concern about their
children being “too young” to worry about the HPV virus. One father stated he
felt that the “HPV vaccine would give [his] daughter a false sense of protection
against sexually transmitted viruses.” This father continued to discuss why he felt
his daughter, at her young age, was unable to understand the purpose of the HPV
vaccine or the significance of the HPV virus. These three parents questioned why
the vaccine was necessary at this stage when their child would not be exposed to
the virus. The recommended age for the HPV vaccine is between 9 and 11 years
of age, and in this rural health clinic, it was recommended at 11 years old.
Because of their concerns about the young age of the children, parents’ hesitancy
about discussing the HPV virus with their children and how the virus is
transmitted sexually was a large part of parental vaccine refusal.
Underlying illness or medical concern. Another common reason for
vaccine refusal was postponing physical exams due to children’s underlying
medical history, whether these were acute or chronic. For example, illnesses such
as type 1 diabetes, cold symptoms, or hives/allergy symptoms were commonly
used as reasons for postponing the vaccination. Parents of children with such
conditions expressed concerns about how their children would react to the HPV
vaccine because of their underlying illnesses. In addition, common reasons for
vaccine refusal or missed doses included being unaware of a required second dose,
missing physical exams, or not scheduling exams. One mother stated, “I was not
told about the vaccine dose schedule during my son’s physical exam.” Noncompliance for completing the vaccine series, misinformation regarding the
purpose of the HPV vaccine, and lack of knowledge regarding the vaccine
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schedule were common concerns in both the literature reviewed for this study and
within this study’s parental interview responses.
Decision to Consent
Vaccine education. The final open-ended question of the in-person
interview was intended to determine what might support parental decisions to
consent to the HPV vaccine. The most common answer to this question was the
need for more vaccine education. Parents verbalized the need for clarification
regarding vaccine purpose, side effects, and the vaccine schedule. One father
stated, “I need to see more data, statistics, and opposing data in regard to the HPV
vaccine.” Another father wanted to know more about the vaccine’s benefits: “I
want to know more about the studies and research about how the HPV vaccine
works.” One mother wanted to hear more about how the vaccine could prevent
future medical problems for her child. Understanding the pros and cons of the
HPV vaccine was a clear theme noted as a result of this open-ended question.
Vaccine schedule reminders. The second common theme indicated by the
data was the need for more reminders and clarification of the vaccine schedule.
Providing vaccine series education to parents could support their decision to
consent to the HPV vaccine and comply with vaccine doses. As parents continued
to discuss the need for further detailed information on the HPV vaccine schedule,
many mentioned how they felt as if frequent reminders and communication with
the clinic providers and staff could increase vaccine compliance, and as a result,
parents would be more likely to consent to vaccinate their child.
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Phone-Call Assessment Data
Vaccine side effects. A phone-call assessment which consisted of four
questions was conducted with each parent one month after the personal interviews.
There was a total of 12 parents who participated in the phone call assessments
(92%). The first assessment question asked if parents recalled their reason for
refusing the HPV vaccine for their children. Once again, the leading reason
parents indicated for their refusal of the vaccine was concerns about the possible
side effects of the vaccine. One mother was concerned about possible
neurological side effects, such as autism or other developmental issues; other
parents feared unknown side effects that perhaps have not been found or shared
with the general public. One mother stated a concern that her daughter might
possibly have “an allergic reaction because the HPV vaccine would be a new
vaccine for her.” As indicated in the literature, parents may require more
information on the vaccine’s actual side effects, for these real-life examples may
decrease parental refusal of the HPV vaccine.
HPV virus sexual connectivity. A common theme noted in the literature
reviewed for this study regarding parental refusal to the HPV vaccine was its
connectivity to sexual behavior or sexually transmitted diseases. This notion was
also present in the data from this study. One father stated that he refused the
vaccine because he was “worried about giving [his] daughter the false illusion of
protection against sexually transmitted diseases.” In this case, health care provider
education could have impacted the father’s understanding of the HPV virus, HPV
related diseases, and overall purpose of the vaccine. Evaluating parental
knowledge of the HPV virus may create parental/provider rapport and create a
clearer parental understanding of the significance of the vaccine for children.
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Lastly, this program’s first follow-up question indicated that the need for further
education and a lack of parental understanding of the vaccine played a large part in
parental refusal of the vaccine. If medical providers cannot clarify the reasons for
vaccine refusal, such refusal cannot be addressed, compliance cannot be achieved,
and preventative health cannot be prioritized.
Teaching Session Lessons
Question number two of the follow-up assessment asked parents to discuss
what they had learned from the teaching session that was conducted by the
researcher following their interviews; overall, parents expressed that, as a result of
the session, they had gained a clearer understanding of the diseases caused by the
HPV virus. One mother specifically stated that she “learned about the benefits of
the vaccine regarding cervical cancer and other cancers that [she] was not aware
could be a concern.” Another mother indicated that, because of the teaching
session, she had learned “how beneficial the vaccine was.”
Parental Opinion to Consent
Understanding the vaccine to consent or refuse. When parents were
asked during the follow-up assessment whether or not they had changed their
opinion about consenting to the HPV vaccine, many parents took the opportunity
to further discuss the vaccine. While assessing parents who had consented to give
the HPV vaccine to their children, this researcher noticed that such parents wanted
to discuss their feelings in more detail; this allowed for the parents to once again
verbalize their understanding and decision to give their child the HPV vaccine,
discuss the importance of the vaccine, and ask more questions about the HPV
vaccine. Out of the 12 parents who participated in the follow-up assessments, one
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parent said she would continue to think about her decision to vaccinate her child.
There was a total of seven parents (58%) who decided to consent to the HPV
vaccine. During the phone call assessment, one mother stated, “I now understand
the importance of this HPV vaccine for my son.” Four parents (33%) continued to
refuse the HPV vaccine for their children. All parents stated that they understood
the HPV vaccine’s purpose after participating in the teaching session with the
researcher.
Parental Consent or Refusal of the
HPV Vaccine
The final question of the phone assessment focused on the decision of the
parent to consent or refuse the administration of the HPV vaccine. After
participating in the interview, teaching session, and phone call assessment, parents
were asked if their decision had changed. Four parents continued to refuse the
vaccine for their children; all three parents had daughters. One parent was unable
to make a decision to consent for her daughter at that time and stated that she
wanted “more time to think about the vaccine and its purpose for her daughter.” A
total of seven parents decided to change their decision to refuse the vaccine and
consented to the administration of the HPV vaccine to their children. Figure 1
demonstrates the parental decisions to consent or to continue to refuse the HPV
vaccine for their children.
As seen by the results in Figure 1, this study’s vaccine program positively
impacted parental decisions regarding the HVP vaccine by encouraging seven
parents (58 %) to change their decision and consent to the vaccine. In the
following chapter, the strengths, limitations, and nursing implications of this HPV
vaccine program study are analyzed.
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Figure 1. Chart depicting HPV vaccine parental consent or refusal.

CHAPTER 5: DISCUSSION
The goal of this HPV vaccine program/study was to identify and evaluate
the reasons for parental refusal of the HPV vaccine in a rural healthcare clinic
setting. In the literature reviewed, there were various methods for identifying
parental vaccine refusal. This study and vaccine program focused on open-ended
in-person interviews, parental vaccine teaching sessions, and a one-month followup assessment which evaluated the parents’ change in consenting to the HPV
vaccine for their children.
Project Outcomes
The primary outcome for this HPV vaccine program was the identification
of reasons for parental refusal to the HPV vaccine. The in-person interview
questions served as a mode of communication between the researcher and parents.
During the interviews, parents were able to answer each question regarding the
HPV vaccine and their reasons for refusing the vaccine for their children. The
second outcome was the use of the teaching session or educational tool which
helped increase parental knowledge of the HPV vaccine. Finally, the follow-up
phone-call assessments conducted one month after parent interviews were used to
evaluate the interviews and teaching sessions’ impact on changing parental refusal
of the HPV vaccine. Overall, this study increased parental understanding of the
HPV vaccine, including the vaccine’s purpose and preventative measures. This
study/vaccine program resulted in several parents’ changing their decision from
refusing the HPV vaccine to consenting to the administration of the HPV vaccine
for their children.
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Nursing Implications
As noted in the literature review provided in this study, parents and
caregivers need more information about the HPV vaccine. Some studies evaluated
the use of a decision aid or someone who could further explain the HPV vaccine
after a medical provider recommended the vaccine. Cipriano et al. (2018) used a
self-directed, computer-based learning tablet application which helped teach
parents about HPV vaccine. Various parents within this study’s interview process
also indicated that more information regarding how the HPV vaccine works could
impact their decision to consent to the vaccine. Parental resistance or fear to
consenting to the HPV vaccine for their children may decrease with a health care
provider’s emphasis on vaccine education and explanation of HPV related
diseases. Clarifying the HPV virus risks, vaccine research, and children’s future
risks may impact the parental decision to consent to the vaccine.
Parental vaccine education. Application of this vaccine program’s
findings may help those in the medical profession to identify parental education
focus points and may decrease parental fears and resistance to the HPV vaccine
for their children. A study conducted by Brown et al. (2017) revealed that a
deciding factor for parental refusal was the feeling that their children were not old
enough for the vaccine (p. 43). As discussed in Chapter 4, during the parental
interviews for this study, parents also expressed that their children’s age/young
age was a factor in refusing to administer the HPV vaccine at the recommended
time. The interviews and assessment results of this study revealed a change in
parental decisions to consent to the HPV vaccine after attending the teaching
session provided by this study’s vaccine program. Thus, stressing the possible
future implications of the HPV virus exposure to parents is an important aspect of
HPV vaccine education.
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Recommended age and sexual behavior. Parental concerns of sexual
behavior or connectivity of sexual activity associated with the HPV vaccine was
also a common theme in both this study and the literature. One study discussed
the parental worry about the HPV vaccine’s being related to sexual intercourse and
behaviors; this concern was a primary factor in many parents’ decision to refuse
the vaccine for their children (Fleming et al., 2018). Multiple studies confirmed
the common reason for parental refusal of the HPV vaccine stemmed from the
early age at which the vaccine was given: many felt the vaccine was given too
early, for children were not sexually active at the time. In this study, some parents
did not feel comfortable with administering the vaccine, believing it was
connected to a virus which was sexually transmitted.
Teaching intervention. This researcher was able to conduct parental
teaching sessions which increased parental vaccine understanding. Healthcare
providers such as nurse practitioners may continue to focus on health promotion
and preventative healthcare, such as vaccine education and parental teaching
support. During this vaccine program, the teaching sessions created opportunities
for parents to not only learn about the HPV vaccine but to also reevaluate their
decision to vaccinate their children. The positive impact of the vaccine education
session was noted in the follow-up assessments, as seven parents (58%) changed
their decisions to consent to and administer the vaccine to their children.
Vaccine schedule and compliance. Understanding the HPV vaccine
schedule and doses can improve patients’ vaccine series compliance. As stated by
various parents during the in-person interviews, the lack of reminders on the HPV
vaccine series doses and scheduling their follow-up appointments impacted their
decision to refuse or complete the HPV vaccine doses. One parent asked about the
vaccine schedule and how the vaccine schedule was reinforced in the rural
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healthcare clinic. Vaccine schedule reminders may vary, and in this study, there
were some parents who were unaware of there being a second HPV vaccine dose.
Healthcare providers such as nurse practitioners may impact vaccine series
compliance by creating better vaccine appointment protocols and reminders in
outpatient rural pediatric clinics.
Strengths
One strength of this study’s HPV vaccine program is that the vaccine
program provided an educational tool: the teaching session increased parents’
understanding of the HPV vaccine and influenced their decision to vaccinate their
children. Another strength of this study was the ability of the researcher to
provide the interview questions, teaching session, and phone call assessments in
the parents’ native language: Spanish or English. Additionally, this study was the
only one in this researcher’s knowledge which used in-person interviews followed
by parental teaching sessions and a one-month follow-up phone assessment which
evaluated the reasons for parental consent to or refusal of the HPV vaccine. The
last strength of this study was the positive impact which the study had on changing
parental decisions to consent to the HPV vaccine for their children.
Limitations
A limitation to this study was the program’s focus on only one specific
patient and parent population in a rural healthcare clinic. Future studies may be
conducted in larger pediatric and family practice clinical health settings,
increasing research data findings. This vaccine program was limited to the parents
whose children received their primary care at the identified rural healthcare clinic.
Another limitation noted in the study was the inability of the researcher to contact
one parent to complete this parent’s follow-up phone call assessment.
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Recommendations for Further Studies
This HPV vaccine program focused on one vaccine, the HPV vaccine,
which is often refused by parents in the rural healthcare clinic setting. Notable in
the results of the one-month follow-up assessments was the fact that parents
learned about the HPV vaccine individually; this positively impacted their
decision to consent to the vaccine. Further research studies may focus on other
recommended pediatric vaccines also refused by parents. Future vaccine
programs may follow this study’s methodology, using in-person interviews, parent
teaching sessions, and one-month follow-up assessments to increase consent to
other vaccines that are often refused. The goals of such vaccine programs should
be as those provided in this study: to address, identify, and evaluate the reasons for
parents’ refusal of these vaccines.
In conducting this study, this researcher found a gap in parental
understanding of the purpose for and schedule of the HPV vaccine. Focusing on
increasing parental vaccine education—whether it incorporates more vaccine
handouts, longer teaching sessions with parents, or introducing vaccine programs
within clinical settings—healthcare providers such as nurse practitioners may
positively impact vaccine education and vaccine series compliance.
Future vaccine programs such as this study may impact clinical vaccine
protocols and promote positive patient care outcomes within pediatric and family
practice settings. For healthcare providers and nurse practitioners, the focus on
health promotion and preventative health measures such as vaccines are a large
part of pediatric patient care. While conducting this vaccine program, the
researcher was able to create a learning environment for parents, conduct vaccine
education, and re-evaluate the parental decision to administer the HPV vaccine to
their children. This vaccine program may be used to promote parental knowledge
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of the HPV vaccine and other vaccines and to impact vaccine series compliance
rates for pediatric and adolescent patients.
Conclusion
This vaccine study identified the reasons for parental refusal of the HPV
vaccine in a pediatric rural health clinic. The vaccine program’s findings noted
the influence of teaching sessions in changing parents’ decisions to consent to the
HPV vaccine for their children. Preventative services such as vaccines,
specifically with the HPV vaccine which prevents diseases caused by the HPV
virus, may be impacted by successfully administering all the doses within the
vaccine series. Healthcare providers, such as nurse practitioners who care for
pediatric patients, should continue to focus on communicating with their patients’
parents by using vaccine programs such as this one to create a positive impact on
their patients’ health.
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APPENDIX A: KINDER SURVEY VACCINE
REFUSAL QUESTIONS
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Kinder Survey Vaccine Refusal Questions
1. How many times has the vaccine been offered to you?
2. Where do you obtain most of your medical information?
3. What was your reason for refusal of HPV vaccine for your child?
4. What would influence your decision to consent for HPV vaccine easier?

APPENDIX B: PERMISSION TO USE KINDER SURVEY
QUESTIONS

44
Permission to Use Kinder Survey Questions

APPENDIX C: DEMOGRAPHIC FORM
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Demographic Form
1. Relationship to patient
2. Educational level
3. Parent age
4. Parent ethnicity
5. Patient sex
6. Patient gender

APPENDIX D: 6 REASONS TO GET HPV VACCINE FOR
YOUR CHILD
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6 Reasons to Get HPV Vaccine for Your Child

APPENDIX E: SCRIPT FOR PHONE CALL ASSESSMENT
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Script for Phone Call Assessment
Hello, my name is Magdalena Ruiz, I am the nurse practitioner and primary
investigator who conducted your face-to-face interview and teaching session that
took place one month ago at Dr. Amu’s pediatric clinic. First, thank you for your
time and willingness to participate in this HPV vaccine research study. I will now
be asking you four questions as part of the study:
1. Can you remember why you refused HPV vaccine for your child?
2. What did you learn about the HPV vaccine after teaching session?
3. Has your opinion changed about consenting vaccine for your child? If
so why?
4. Will you consent or refuse HPV vaccine for your child?
Thank you so much for your time and participation in this vaccine study. If
you have any future questions about research, please feel free to contact me at
559-743-7340.
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